Live Breaking News & Updates on Oncodermatology Program

Stay updated with breaking news from Oncodermatology program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lutris Pharma Doses First U.S. Patients in Phase 2 Trial of LUT014 -- a Topical Gel for the Reduction of Dose-Limiting Acneiform Lesions -- in Metastatic Colorectal Cancer Patients Treated with EGFR Inhibitor Therapy